文献速递主动脉疾病

腹主动脉瘤直径与患者身高比值与症状性表现及死亡率的相关性

Association of abdominal aortic aneurysm diameter indexed to patient height with symptomatic presentation and mortality.
PubMed 文献 · J Vasc Surg · 2021-11-15

基于血管质量倡议数据库(2003-2020)64,595例腹主动脉瘤修复患者,提出直径-身高指数(DHI),其升高与症状性表现风险增加相关(aOR 1.70),仅无症状患者DHI升高与5年死亡风险增加相关(aHR 1.20),症状性患者DHI升高与30天死亡风险轻度增加相关(aOR 1.08)。

要点

  • DHI每增加1单位,症状性表现风险增加(aOR 1.70,95%CI 1.59-1.83)。
  • DHI预测症状性状态的ROC曲线下面积略高于AAA直径(0.702 vs 0.695)。
  • 仅无症状患者中DHI升高与5年死亡风险增加相关(aHR 1.20)。

核心结论

  • DHI是一种简单工具,在预测症状性表现方面可能比AAA直径更有效。
  • DHI因性别和种族而异,可能有助于个体化预后评估。
  • DHI可额外预测无症状AAA患者修复术后5年死亡率。
  • 然而,两组30天死亡率的比值比保持相似。

研究设计与样本

  • 使用血管质量倡议数据库(2003-2020)识别接受开放或腔内AAA修复的患者。
  • DHI定义为AAA直径(厘米)除以身高(厘米),得分为1至10。
  • 采用多变量逻辑回归评估症状性表现(包括破裂)和30天死亡风险,绘制ROC曲线,并用生存分析确定5年死亡风险。

主要发现

  • 共识别64,595例患者,其中16.3%表现为症状性AAA(包括破裂)。
  • 症状性AAA中69.8%接受腔内修复,无症状AAA中84.3%接受腔内修复(P < .001)。
  • 症状组平均DHI高于无症状组(3.92 ± 1.1 vs 3.24 ± 0.7;P < .001)。
  • DHI升高与症状性表现风险增加相关(aOR 1.70;95%CI 1.59-1.83;P < .001)。
  • DHI预测症状性状态的ROC曲线下面积略高于AAA直径(0.702;95%CI 0.695-0.708 vs 0.695;95%CI 0.688-0.701;P < .001)。

关键数值与推荐

  • 症状性表现风险随DHI增加而升高(aOR 1.70;95%CI 1.59-1.83;P < .001)。
  • 主动吸烟增加症状性表现风险(aOR 1.38;95%CI 1.28-1.51;P < .001)。
  • 术前使用他汀类药物降低症状性表现风险(aOR 0.58;95%CI 0.53-0.64;P < .001)。
  • 术前使用β受体阻滞剂降低症状性表现风险(aOR 0.76;95%CI 0.69-0.84;P < .001)。
  • 症状性AAA患者中DHI每增加1单位与30天死亡风险增加相关(aOR 1.08;95%CI 1.01-1.15;P < .001);无症状AAA患者中DHI升高与5年死亡风险增加相关(aHR 1.20;95%CI 1.13-1.29;P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current guidelines have recommended repair of abdominal aortic aneurysms (AAAs) according to the maximal AAA diameter and/or its growth rate. However, many studies have suggested that the AAA diameter alone is not sufficient to predict the risk of rupture or symptomatic presentation. Several investigators have attempted to relate the AAA diameter to the body surface area in predicting for rupture. However, these calculations have not resulted in conclusive evidence. We sought in the present analysis to introduce a novel diameter-to-height index (DHI) and test its utility in predicting for symptomatic presentations, including rupture and 30-day and 5-year mortality. METHODS: The Vascular Quality Initiative database (2003-2020) was used to identify patients who had undergone open or endovascular AAA repair. The DHI was defined as the AAA diameter in centimeters divided by the height in centimeters, yielding a score of 1 to 10. Multivariable logistic regression analysis was performed to assess the risk of symptomatic presentation, including rupture and 30-day mortality. Receiver operating characteristic curves were plotted, and survival analysis techniques were used to determine the hazard of 5-year mortality. RESULTS: A total of 64,595 patients were identified, of whom, 16.3% had presented with symptomatic AAAs, including rupture. Endovascular AAA repair was performed for 69.8% of the symptomatic AAAs and 84.3% of asymptomatic AAAs (P < .001). The symptomatic group were more likely to be women (24.6% vs 19.8%; P < .001) and Black (7.81% vs 4.44%; P < .001). The mean DHI was higher in the symptomatic group than in the asymptomatic group (mean DHI, 3.92 ± 1.1 vs 3.24 ± 0.7; P < .001). The adjusted odds of a symptomatic presentation increased with an increasing DHI (adjusted odds ratio [aOR], 1.70; 95% confidence interval [CI], 1.59-1.83; P < .001). Active smoking increased the risk of a symptomatic presentation (aOR, 1.38; 95% CI, 1.28-1.51; P < .001). However, the use of preoperative statins and beta-blockers significantly reduced the odds of a symptomatic presentation (aOR, 0.58; 95% CI, 0.53-0.64; P < .001; and aOR, 0.76; 95% CI, 0.69-0.84; P < .001), respectively. Compared with the AAA diameter, the receiver operating characteristic curve for the DHI to predict for symptomatic status was slightly, but significantly, higher (aOR, 0.702; 95% CI, 0.695-0.708; vs aOR, 0.695; 95% CI, 0.688-0.701; P < .001). The DHI increment was associated with a 1.08 greater odds of 30-day mortality (aOR, 1.08; 95% CI, 1.01-1.15; P < .001) for those with symptomatic AAAs. Similarly, the hazard of 5-year mortality was increased with an increasing DHI (adjusted hazard ratio, 1.20; 95% CI, 1.13-1.29; P < .001) only for those with asymptomatic AAAs. CONCLUSIONS: The DHI is a simple tool that could be more effective than the AAA diameter in predicting for symptomatic presentations. The DHI varied by sex and race, which could collectively help to provide an individualized prognosis. The DHI can additionally predict the 5-year mortality after AAA repair for those with asymptomatic AAAs only. However, the odds of 30-day mortality remained similar in both groups.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Khan MA, Nejim B, Faateh M, et al. Association of abdominal aortic aneurysm diameter indexed to patient height with symptomatic presentation and mortality. J Vasc Surg. 2021. PMID: 34793921. doi:10.1016/j.jvs.2021.10.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。